This website uses cookies to make the content more user-friendly and effective. By using this website, you agree to the use of cookies. You can find additonal information about the use of cookies and the possibility of objecting to the use of cookies here.

31 March - 2 April 2020 // Nuremberg, Germany

Posting print layout

What information should be shown in the print layout?

Create print layout
Exhibitors & Products MedtecLIVE 2019
Zoom product LOGO_Cardiology

Cardiology

LOGO_Cardiology

Cardiology

Request information Request information

Contact us

Please enter your personal information and desired appointment. You can also leave us a message.

Your personal information

Your message for us

Desired appointment during the exhibition

* Compulsory fields you must fill in.

Information on data protection can be found here.

Send
Your message has been sent.

You do not have a registration yet? Register now and use all advantages of the Exhibitors and Products Database, the supporting programme and the TicketShop.

An error has occurred.

Patients suffering from acute or chronic lung diseases are unable to sufficiently clear the carbon dioxide generated by metabolic processes in their bodies by exhaling it via the lung. CCORE, a spinoff of the Medical University of Vienna, is developing new methods for minimally invasive blood purification. The company is developing a solution to prevent lung injury caused by invasive ventilation methods or even avoid, or largely reduce, the need for invasive ventilation.

Angel Valve Vienna is dedicated to the development of sophisticated treatment concepts for mitral valve repair. With the current lead product, the Mitral Butterfly® implant, the company focuses on the minimally invasive intervention of mitral regurgitation, a condition that affects 2-3% of the world´s population.

AFreeze uses cryotechnology for the treatment of cardiac arrhythmia. The company’s technology is a device that shock-freezes tissue in the left atrium via a catheter, thereby eliminating all three possible mechanisms of arterial fibrillation.

EMCOOLS Medical Cooling Systems develops and markets novel non-invasive cooling devices to benefit neurologic outcomes after ischaemic events such as myocardial infarction, stroke and cardiac arrest. In pre-hospital and in-hospital settings, EMCOOLS products deliver a perfect synergy of ease of use and best-in-class product performance.

Miracor Medical Systems is commercialising a new technology for improving outcomes for heart attack patients. Using an approach called Pressure-controlled Intermittent Coronary Sinus Occlusion (PICSO), the method seeks to improve blood flow in the heart tissue and improve overall heart function after a severe heart attack.

You decided to attend the MedtecLIVE? Get your tickets at the TicketShop



top

The selected entry has been placed in your favourites!

If you register you can save your favourites permanently and access all entries even when underway – via laptop or tablet.

You can register an account here to save your settings in the Exhibitors and Products Database and as well as in the Supporting Programme.The registration is not for the TicketShop and ExhibitorShop.

Register now

Your advantages at a glance:

  • Advantage Save your favourites permanently. Use the instant access – mobile too, anytime and anywhere – incl. memo function.
  • Advantage The optional newsletter gives you regular up-to-date information about new exhibitors and products – matched to your interests.
  • Advantage Call up your favourites mobile too! Simply log in and access them at anytime.